Date published: 2025-11-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

Quinine hydrochloride dihydrate (CAS 6119-47-7)

0.0(0)
Write a reviewAsk a question

Application:
Quinine hydrochloride dihydrate is a Potassium channel blocker
CAS Number:
6119-47-7
Purity:
≥99%
Molecular Weight:
396.91
Molecular Formula:
C20H24N2O2•HCl•2H2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Quinine hydrochloride dihydrate is used in research applications that focus on chiral resolution processes and the study of stereochemistry due to its optically active nature. Researchers utilize this compound in the field of analytical chemistry, particularly in chiral chromatographic techniques, to separate and analyze enantiomers of different substances. The compound is also a subject of interest in the study of molecular interactions in solution, as the presence of both the quinine alkaloid structure and the hydrochloride salt can influence solubility and stability. Additionally, quinine hydrochloride dihydrate is investigated for its role in the crystallization processes of various organic molecules, where it may act as a template or nucleation agent due to its well-defined dihydrate crystal structure. In the realm of material sciences, this compound is explored for its potential incorporation into advanced materials with specific optical properties, leveraging its inherent chirality.


Quinine hydrochloride dihydrate (CAS 6119-47-7) References

  1. Development of a model for robust and exploratory analysis of the rodent brief-access taste aversion data.  |  Soto, J., et al. 2015. Eur J Pharm Biopharm. 91: 47-51. PMID: 25619919
  2. The development of basic taste sensitivity and preferences in children.  |  Fry Vennerød, FF., et al. 2018. Appetite. 127: 130-137. PMID: 29729324
  3. Rats can predict aversiveness of Active Pharmaceutical Ingredients.  |  Soto, J., et al. 2018. Eur J Pharm Biopharm. 133: 77-84. PMID: 30267837
  4. Synthesis of Saponite Based Nanocomposites to Improve the Controlled Oral Drug Release of Model Drug Quinine Hydrochloride Dihydrate.  |  S, K., et al. 2019. Pharmaceuticals (Basel). 12: PMID: 31295860
  5. Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs.  |  Dinevska, M., et al. 2020. Cancers (Basel). 12: PMID: 33050088
  6. Utilising Co-Axial Electrospinning as a Taste-Masking Technology for Paediatric Drug Delivery.  |  Abdelhakim, HE., et al. 2021. Pharmaceutics. 13: PMID: 34683958

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Quinine hydrochloride dihydrate, 5 g

sc-212619
5 g
$63.00

Quinine hydrochloride dihydrate, 25 g

sc-212619A
25 g
$210.00